ArteraAI

ArteraAI is happy to announce that the #ArteraAI Prostate Test is the First-and-Only Predictive Test for Therapy Personalization in the 2024 National Comprehensive Cancer Network® (NCCN®) Guidelines® for Prostate Cancer. Our test is the only test included for its predictive performance, and also the first AI-enabled predictive and #prognostic test to be recommended in the guidelines for localized #prostatecancer. This is an exciting step forward for ArteraAI. As Andre Esteva, PhD, CEO and Co-Founder of ArteraAI said, “This significant milestone not only celebrates ArteraAI's success but also paves the way for the integration of AI-enabled solutions into clinical practice, illustrating their potential to enhance personalized patient care.” Read the announcement here:

Amidst the buzz around #AI in healthcare, let's not forget the real reason for it all - patient care. With all the advances in cancer treatments these days, the hardest task is often left to the patient on making a life-changing decision. Read the insights from Andre Esteva, PhD on how #ArteraAI can ease the stress patients face when deciding on the best treatment option for them. https://bit.ly/3XUAcd9"

ICYMI: UroToday + GU OncToday hosted a multi-disciplinary panel discussion on the impact of AI on #prostatecancer risk stratification. Dr. Alicia Morgans, a GU medical oncologist from Dana-Farber Cancer Institute, shared her thoughts on the #ArteraAI Prostate Test and how she uses it in her practice. Hear more insights from Zachary Klaassen, Dr. Neal Shore, and Dr. Dan Spratt in the full interview: [https://bit.ly/3VZHvhi].

#MensHealthMonth may be over, but spreading awareness of the importance of #menshealth doesn't stop there. Artera Co-Founder Felix Feng, along with other experts from the Rockwell Centers for Sexual Medicine and Wellness and Mayo Clinic, discuss the steps men can take to help lower their #prostatecancer risk, with Men's Health South Africa:

Appreciate Dr. James Yu and Dr. Julian Hong from Cancer Network for featuring the Artera #MMAI platform on your podcast. Definitely a great summary of all sorts of AI innovations in healthcare and worth a listen! https://lnkd.in/efu8QWXr

Get to know #ArteraAI's Yi Ren, Biostatistician III, our July Employee of the Month! "Yi has made invaluable impact across prostate model dev workstreams over the past 2 quarters and has been instrumental to our progress. He is incredibly efficient and productive, balancing work across multiple teams. He is respected as a thought leader among cross functional teams and is an excellent collaborator." Congratulations, Yi! 👏 We're proud to have you on our team. #personalizedcancercare #prostatecancer #AI #precisionmedicine

As a precision medicine company, we're very fortunate to have #prostatecancer experts like Trevor Royce MD MPH FASCO on staff to answer any clinical questions we have. Check out his latest advice on Healthline Media about various #lifestyle risk factors to consider. https://lnkd.in/e-nMTVPi

The #ArteraAI Prostate Test is your compass to choosing the right #prostatecancer treatment, helping physicians determine if treatment intensification is needed. Patients who find they will benefit from ADT can be confident in their decision to proceed with treatment, knowing that they are on an ideal course for their care. Conversely, patients whose results indicate no clear benefit from ADT can also feel confident in their choice to forego the treatment, assured that they are making the best decision for their health. Learn how the integration of #AI technology in #cancercare can improve accuracy and aid in clinical decision-making:

A recent study in European Urology found an alarming correlation in men diagnosed with high-risk #prostatecancer facing an elevated risk of depression and suicide. How can AI-driven cancer care help? Tim Showalter, Chief Medical Officer at Artera, shares his perspective on how embracing the power of #AI could allow clinicians to forge a collaborative alliance with patients, delivering clear conversations, personalized treatment, and more hope amid the diagnosis, in Psychology Today: https://bit.ly/3yIfNh9 #MensHealthWeek #MensHealthMonth #MensMentalHealth

While Artera is a global company, we are extremely proud of the #freedom and #entrepreneurial spirit that is core to the United States. We wish all our customers - physicians, patients, and research scientists a wonderful 4th of July!